The Cancer Genome Atlas (TCGA) project has revealed the distribution of patients with BRCA1/2 mutations and/or HRD in ovarian serous carcinoma based on molecular profiling.11 The gene discussed is BRCA1; the disease is ovarian serous carcinoma.